Every year, tens of thousands of women undergo surgical procedures to treat conditions like urinary incontinence and pelvic organ prolapse. In many cases, transvaginal mesh implants are used to provide support to patients’ internal organs. However, these devices are notorious for causing serious harm.
Studies show a transvaginal mesh failure can result from the devices moving, deteriorating, or becoming embedded within the body. This can result in severe pain, swelling, irritation, and even bowel or organ perforation that requires corrective surgery.
To help cover the damages associated with a transvaginal mesh failure, some victims filed civil lawsuits against the makers of these faulty devices. Now, it seems one company is hoping to resolve a large number of these types of claims through a proposed settlement.
According to Bloomberg Business, transvaginal mesh manufacturer, C.R. Bard, Inc., has offered $200 million to resolve roughly 3,000 cases involving the failure of their transvaginal mesh product. Experts say that if the terms of the agreement are accepted and approved, each victim will receive roughly $67,000 in compensation.
The decision to settle comes on the heels of C.R. Bard being ordered to pay $2 million to a woman harmed by the company’s transvaginal mesh product in 2013.
The Indiana defective product lawyers at Stewart & Stewart Attorneys are hopeful a resolution can be reached soon.